Weill Cornell Medicine receives $1.5M grant to predict prostate cancer bone metastasis

FHS
June 25, 2024
6:50 pm

Weill Cornell Medicine received a $1.5 million grant from the U.S. Department of Defense Prostate Cancer Research Program to develop new approaches for predicting the spread of cancer cells to the bone in men with prostate cancer, using tumor samples taken at early stages of the disease.

Finnish biotech startup Solu raises €1M to combat global antibiotic resistance

Solu, founded in 2022, is a Finnish biotechnology company focusing on combating antibiotic resistance by building the world’s most extensive pathogen DNA library. Solu’s product

June 15, 2023

Woman Who Can Smell Parkinson’s; Alzheimer’s Blood Test Standards; ARBs and Epilepsy

The New York Times profiled Joy Milne, a super-smeller who can detect Parkinson’s disease and the co-author of several papers on the topic. Cold and

June 19, 2024

Acutus laying off 65% of employees to focus solely on Medtronic heart device deal

Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Acutus Medical is laying off approximately

November 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.